Publications

Abbreviated Publications List for Julie Bukar, Managing Director, JGB BioPharma Consulting:
J Patton, J Bukar, M Eldon; Clinical Pharmacokinetics and Pharmacodynamics of Inhaled Insulin, Clinical Pharmacokinetics , 43 (12):781-801 (21); 2004

J Patton, J Bukar, S Nagarajan; Inhaled Insulin, Advanced Drug Delivery Reviews , 35: 235 -247, 1999

J Hatton, R Rapp, K Kudsk, RO Brown, MS Leur, J Bukar, S Chen, C McClain, N Gesundheit, R Dempsey, B Young; Intravenous insulin-like growth factor-I in moderate to severe head injury: a phase II safety and efficacy trial; J Neurosurgery , 86:779-786, 1997.

PDK Lee, JM Pivarnik, J Bukar, N Muurahainen, PS Berry, PR Skolnik, JL Nerad, KA Kudsk, L Jackson, KJ Ellis, N Gesundheit; A randomized, placebo-controlled trial of combined insulin-like growth factor-I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection; JCEM , 81(8):2968-2975, 1996

KA Kudsk, C Mowatt-Larssen, J Bukar, S Oellerich, T Fabian, DL Den R Brown; Effect of rhIGF-I and early TPN on immune depression following severe head injury; Archives of Surgery , 129:66-71, 1994.

]SA Lieberman, J Bukar, SA Chen, SA Chen, M Mohler, AC Celniker, PG Compton; The effect of human insulin-like growth factor-I on total and free IGF-I concentrations, IGF binding proteins, and glycemic response in humans, JCEM , 75(1):30-36, 1992.

J Bukar, N Mezitis, V Saitas, FX Pi-Sunyer; Frozen desserts and glycemic response in well-controlled NIDDM patients, Diabetes Care , 13(4):382-285, 1990